Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Daniela Diomede"'
Autor:
Michelina Dargenio, Silvana Capalbo, Mario Delia, Daniela Diomede, Vincenzo Liso, Antonia Chiefa, Gianfranco Favia
Publikováno v:
International Journal of Hematology. 83:379-384
It has been demonstrated that bisphosphonate-based supportive therapy (pamidronate or zoledronate) reduces skeletal events (onset or progression of osteolytic lesions) both in patients with multiple myeloma (MM) and in cancer patients with bone metas
Autor:
Mario Delia, Daniela Diomede, Michela Dargenio, Lucrezia Garofalo, Arcangelo Liso, Vincenzo Liso, Silvana Capalbo
Publikováno v:
Medical Oncology. 20:389-396
We report the use of Alemtuzumab (Campath-1H) as salvage treatment in three patients with advanced mycosis fungoides/Sézary syndrome who had previously been treated with conventional chemotherapy. Two patients (case 1 and case 2), aged 42 and 68 yr,
Publikováno v:
Acta Oncologica. 46:262-264
The activity of bortezomib has been evaluated in large clinical trials on relapsed and/or refractory multiple myeloma (MM) [1] but not on plasma cell leukemia (PCL), due to its relative rarity. So ...
Autor:
Cosima Battista, Michela Dargenio, Mario Delia, Angela Ciancio, Daniela Diomede, Gaetano De Santis, Silvana Capalbo, Vincenzo Liso
Publikováno v:
Acta haematologica. 108(2)
Serum levels of tumor necrosis factor-alpha (TNF-alpha) and of erythropoietin (Epo) have been evaluated in 100 patients with B-cell chronic lymphocytic leukemia (CLL) in order to determine whether these factors could be significant in the development
Autor:
Antonella Chiefa, Rosalia Ricco, Daniela Diomede, Michelina Dargenio, Mario Delia, Silvana Capalbo, Vincenzo Liso, Anna Napoli
Publikováno v:
Annals of Hematology. 84:625-626
Autor:
Silvana Capalbo, Mario Delia, Michela Dargenio, Arcangelo Liso, Daniela Diomede, Lucrezia Garofalo, Vincenzo Liso
Publikováno v:
Medical Oncology; Dec2003, Vol. 20 Issue 4, p389-396, 8p